These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

199 related items for PubMed ID: 9183228

  • 1. Cholesterol and coronary heart disease. The 21st century.
    Grundy SM.
    Arch Intern Med; 1997 Jun 09; 157(11):1177-84. PubMed ID: 9183228
    [Abstract] [Full Text] [Related]

  • 2. A tertiary care hospital-based study of conventional risk factors including lipid profile in proven coronary artery disease.
    Goel PK, Bharti BB, Pandey CM, Singh U, Tewari S, Kapoor A, Garg N, Sinha N.
    Indian Heart J; 2003 Jun 09; 55(3):234-40. PubMed ID: 14560932
    [Abstract] [Full Text] [Related]

  • 3. Cholesterol: precursor to many lipid disorders.
    Jones PH.
    Am J Manag Care; 2001 Aug 09; 7(9 Suppl):S289-98. PubMed ID: 11517815
    [Abstract] [Full Text] [Related]

  • 4. Prevalence of high plasma triglyceride combined with low HDL-C levels and its association with smoking, hypertension, obesity, diabetes, sedentariness and LDL-C levels in the Canadian population. Canadian Heart Health Surveys Research Group.
    Connelly PW, Petrasovits A, Stachenko S, MacLean DR, Little JA, Chockalingam A.
    Can J Cardiol; 1999 Apr 09; 15(4):428-33. PubMed ID: 10322252
    [Abstract] [Full Text] [Related]

  • 5. [Statins in primary prevention of coronary heart disease].
    Paulweber B.
    Wien Med Wochenschr; 1999 Apr 09; 149(5-6):129-38. PubMed ID: 10408004
    [Abstract] [Full Text] [Related]

  • 6. Lipoprotein Lp(a) excess and coronary heart disease.
    Stein JH, Rosenson RS.
    Arch Intern Med; 1997 Jun 09; 157(11):1170-6. PubMed ID: 9183227
    [Abstract] [Full Text] [Related]

  • 7. European and American recommendations for coronary heart disease prevention.
    Wood D.
    Eur Heart J; 1998 Feb 09; 19 Suppl A():A12-9. PubMed ID: 9519337
    [Abstract] [Full Text] [Related]

  • 8. Management of hypercholesterolaemia in the patient with diabetes.
    Packard C, Olsson AG.
    Int J Clin Pract Suppl; 2002 Jul 09; (130):27-32. PubMed ID: 12296606
    [Abstract] [Full Text] [Related]

  • 9. Pharmacologic management of isolated low high-density lipoprotein syndrome.
    Bermúdez V, Cano R, Cano C, Bermúdez F, Arraiz N, Acosta L, Finol F, Pabón MR, Amell A, Reyna N, Hidalgo J, Kendall P, Manuel V, Hernández R.
    Am J Ther; 2008 Jul 09; 15(4):377-88. PubMed ID: 18645343
    [Abstract] [Full Text] [Related]

  • 10. Prevalence of low high-density lipoprotein cholesterol in patients with documented coronary heart disease or risk equivalent and controlled low-density lipoprotein cholesterol.
    Alsheikh-Ali AA, Lin JL, Abourjaily P, Ahearn D, Kuvin JT, Karas RH.
    Am J Cardiol; 2007 Nov 15; 100(10):1499-501. PubMed ID: 17996508
    [Abstract] [Full Text] [Related]

  • 11. The prevalence of hyperlipidemia in women and its association with use of oral contraceptives, sex hormone replacement therapy and nonlipid coronary artery disease risk factors. Canadian Heart Health Surveys Research Group.
    Connelly PW, Stachenko S, MacLean DR, Petrasovits A, Little JA.
    Can J Cardiol; 1999 Apr 15; 15(4):419-27. PubMed ID: 10322251
    [Abstract] [Full Text] [Related]

  • 12. A long-term follow-up study of serum lipid levels and coronary heart disease in the elderly.
    Li JZ, Chen ML, Wang S, Dong J, Zeng P, Hou LW.
    Chin Med J (Engl); 2004 Feb 15; 117(2):163-7. PubMed ID: 14975195
    [Abstract] [Full Text] [Related]

  • 13. Coronary artery disease prognosis and C-reactive protein levels improve in proportion to percent lowering of low-density lipoprotein.
    O'Keefe JH, Cordain L, Jones PG, Abuissa H.
    Am J Cardiol; 2006 Jul 01; 98(1):135-9. PubMed ID: 16784936
    [Abstract] [Full Text] [Related]

  • 14. Pharmacologic options for aggressive low-density lipoprotein cholesterol lowering: benefits versus risks.
    McKenney JM.
    Am J Cardiol; 2005 Aug 22; 96(4A):60E-66E. PubMed ID: 16098846
    [Abstract] [Full Text] [Related]

  • 15. [Cholesterolemia control in Spain, 2000. A tool for cardiovascular disease prevention. Ministry of Health and Consumption, Spanish Society of Cardiology and Spanish Society of Arteriosclerosis].
    Rev Esp Salud Publica; 2000 Aug 22; 74(3):215-53. PubMed ID: 10918811
    [Abstract] [Full Text] [Related]

  • 16. Cholesterol and coronary events. The current thinking.
    Jones PH.
    Postgrad Med; 2003 Apr 22; 113(4 Suppl):5-14. PubMed ID: 19667618
    [Abstract] [Full Text] [Related]

  • 17. [Cardiovascular risk factors and prevention in women: similarities and differences].
    Sclavo M.
    Ital Heart J Suppl; 2001 Feb 22; 2(2):125-41. PubMed ID: 11255880
    [Abstract] [Full Text] [Related]

  • 18. Management of dyslipidemia in primary care.
    Alzahrani T, Marrat S, Haider A.
    Can J Cardiol; 2003 Dec 22; 19(13):1499-502. PubMed ID: 14760440
    [Abstract] [Full Text] [Related]

  • 19. Raising high-density lipoprotein cholesterol with reduction of cardiovascular risk: the role of nicotinic acid--a position paper developed by the European Consensus Panel on HDL-C.
    Chapman MJ, Assmann G, Fruchart JC, Shepherd J, Sirtori C, European Consensus Panel on HDL-C.
    Curr Med Res Opin; 2004 Aug 22; 20(8):1253-68. PubMed ID: 15324528
    [Abstract] [Full Text] [Related]

  • 20. High-density lipoprotein cholesterol and triglycerides as therapeutic targets for preventing and treating coronary artery disease.
    Gotto AM.
    Am Heart J; 2002 Dec 22; 144(6 Suppl):S33-42. PubMed ID: 12486414
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.